Draw
|
Currency :
Structure Search
AG0039L8
6055-19-2 | 2-[Bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide monohydrate
![Chemical structure of 2-[Bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide monohydrate, CAS 6055-19-2](https://api.angenesci.com/structure/1304/6055-19-2.png)
AG0039L8
SDS
COA
Add to Cart
Request For Quotation
- mg
- g
- kg
- ml
- L
无数据
无数据
- mg
- g
- kg
- ml
- L
无数据
| CAS Number | 6055-19-2 |
| Catalog Number | AG0039L8(AGN-PC-0SWK25) |
| Chemical Name | 2-[Bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide monohydrate |
| IUPAC Name | N,N-bis(2-chloroethyl)-2-oxo-1,3,2λ5-oxazaphosphinan-2-amine;hydrate |
| InChI | InChI=1S/C7H15Cl2N2O2P.H2O/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14;/h1-7H2,(H,10,12);1H2 |
| InChI Key | PWOQRKCAHTVFLB-UHFFFAOYSA-N |
| MDL Number | MFCD00149395 |
| Molecular Formula | C7H17Cl2N2O3P |
| Molecular Weight | 279.1012 |
| SMILES | O.ClCCN(P1(OCCCN1)=O)CCCl |
| UN Number | 2811 |
| Synonyms | (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,
B 518,
B-518,
B518,
Cyclophosphamide,
Cyclophosphamide Anhydrous,
Cyclophosphamide Monohydrate,
Cyclophosphamide, (R)-Isomer,
Cyclophosphamide, (S)-Isomer,
Cyclophosphane,
Cytophosphan,
Cytophosphane,
Cytoxan,
Endoxan,
Neosar,
NSC 26271,
NSC-26271,
NSC26271,
Procytox,
Sendoxan,
Cyclophosphamide monohydrate,
6055-19-2,
Cyclophosphamide hydrate,
Cytoxan,
Endoxon,
Endoxan monohydrate,
Ciclophosphamide hydrat,
2-(Bis(2-chloroethyl)amino)-1,3,2-oxazaphosphinane 2-oxide hydrate,
Cytoxan hydrate,
Cyclophosphamide (hydrate),
Endoxan A,
Cyclophosphamide (hydrated),
MFCD00149395,
CCRIS 7469,
MLS001306483,
CHEBI:4026,
1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridine monohydrate,
Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester monohydrate,
Revimmune,
2-(Bis(2-chloroethyl)amino)-1-oxa-3-aza-2-phosphocyclohexane 2-oxide monohydrate,
2-(Di(2-chloroethyl)amino)-1-oxa-3-aza-2-phosphacyclohexane-2-oxide monohydrate,
(Bis(chloro-2-ethyl)amino)-2-tetrahydro-3,4,5,6-oxazaphosphorine-1,3,2-oxide-2 monohydrate,
2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide, monohydrate,
N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxaphosphorin-2-amine, 2-oxide monohydrate,
N,N-Bis(beta-chloroethyl)-N',O-trimethylenephosphoric acid ester diamide monohydrate,
Cytoxan (TN),
DSSTox_CID_4888,
2-[Bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide,
N,N-Bis(beta-chloroethyl)-N',O-propylenephosphoric acid ester amide monohydrate,
N,N-Bis(beta-cloraethyl) N'-O-propylenphosphorildiamid monohydratum [Romanian],
(+-)-2-(Bis(2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide monohydrate,
2-(Bis(2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide monohydrate,
Cyclic N',O-propylene ester of N,N-bis(2-chloroethyl)phosphorodiamidic acid monohydrate,
DSSTox_RID_77569,
N,N-Di(2-chloroethyl)amino-N,O-propylene phosphoric acid ester diamide monohydrate,
C7H17Cl2N2O3P,
DSSTox_GSID_24888,
Cyclophosphamide monohydrate, 97%,
N,N-bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide hydrate,
2H-1,3,2-Oxazaphosphorine, tetrahydro-2-(bis(2-chloroethyl)amino)-, 2-oxide, monohydrate,
N,N-bis(2-Chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine-2-oxide Monohydrate,
2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide, monohydrate, (+-),
CPD000718805,
CAS-6055-19-2,
Cytoxan (Lyophilized),
NCGC00015209-05,
Cyclophsphamide,
C7H15Cl2N2O2P.H2O,
N,N-bis(2-chloroethyl)-2-oxo-1,3,2?^{5}-oxazaphosphinan-2-amine;hydrate,
Prestwick_137,
Neosar (TN),
Cyclophosphamide [USP:INN:BAN:JAN],
Cyclophosphamide,(S),
Cyclophosphamide [USAN:INN:BAN:JAN],
Cyclophosphamide (USP),
AC1L2KDB,
Cyclophosphamidemonohydrate,
cyclophosphamide-monohydrate,
AC1Q59AM,
SCHEMBL6071,
50-18-0 (anhydrous),
SPECTRUM1500213,
CHEMBL1200796,
DTXSID6024888,
CTK6H8350,
Cyclophosphamide hydrate (JP17),
Cyclophosphamide tablets (JP17),
HMS500M08,
PWOQRKCAHTVFLB-UHFFFAOYSA-N,
HMS1920C04,
HMS2091I12,
HMS2234I13,
HMS3259P15,
HMS3370O11,
BCP22663,
Tox21_110100,
Tox21_201503,
Tox21_300529,
CCG-40013,
HY-17420A,
LS-265,
N,N-Bis(beta-cloraethyl) N'-O-propylenphosphorildiamid monohydratum,
s2057,
AKOS009144593,
Tox21_110100_1,
2-[bis(2-chloroethyl)amino]-1,3,2,
AC-1741,
BCP9000569,
CS-5005,
NC00662,
KS-00000V53,
Cyclophosphamide monohydrate, ISOPAC(R),
NCGC00015209-11,
NCGC00091741-01,
NCGC00091741-04,
NCGC00094636-01,
NCGC00094636-02,
NCGC00094636-03,
NCGC00094636-04,
NCGC00180900-01,
NCGC00254543-01,
NCGC00259054-01,
4CA-0425,
AK117774,
AN-14668,
AS-13677,
BC203866,
BP-12392,
Cyclophosphamide monohydrate, bulk package,
H538,
SAM002548983,
SAM002564197,
SMR000718805,
BCP0726000113,
AB0006982,
AB2000461,
FT-0624277,
ST24039565,
SW199628-3,
EN300-52512,
C06933,
D00287,
J10095,
M-1398,
29545-EP2308812A2,
29545-EP2311842A2,
Cyclophosphamide monohydrate, analytical standard,
055C192,
I05-073,
I05-0073,
SR-01000075737-4,
UNII-8N3DW7272P component PWOQRKCAHTVFLB-UQKRIMTDSA-N,
Cyclophosphamide, European Pharmacopoeia (EP) Reference Standard,
TRANSGENIC MODEL EVALUATION (CYCLOPHOSPHAMIDE MONOHYDRATE),
2-[bis(2-chloroethyl)amino]-1,3,2lambda-oxazaphosphinan-2-one hydrate,
Cyclophosphamide, United States Pharmacopeia (USP) Reference Standard,
N,N-bis(2-chloroethyl)-2-oxo-1,3,2$l^{5}-oxazaphosphinan-2-amine hydrate,
2-[BIS(2-CHLOROETHYL)AMINO]-1,3,2$L^{5}-OXAZAPHOSPHINAN-2-ONE HYDRATE,
2-[Bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide monohydrate,
CYCLOPHOSPHAMIDE MONOHYDRATE (SEE ALSO CYCLOPHOSPHAMIDE (CAS 50-18-0)),
Cyclophosphamide, Pharmaceutical Secondary Standard; Certified Reference Material,
N,N-bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide--water (1/1),
cyclophosphamide,
Neosar,
null,
Endoxana,
Endoxan,
Lyophilized Cytoxan,
UNII-8N3DW7272P,
6055-19-2 (hydrate),
alkylating agent: crosslinks DNA,
NSC 26271,
8N3DW7272P,
CID22420,
DRG-0048,
NA2811,
NSC-26271,
UN2811,
CS-O-06288,
Cyclophosphamide [USAN:BAN:INN:JAN],
C7-H15-Cl2-N2-O2-P.H2-O,
N,N-bis(2-chloroethyl)-2-oxo-1,3,2,
A4232,
SR-01000075737,
Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester,
1-bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin monohydrate,
2-[Bis(2-chloroethyl)amino]tetrahydro-1,3,2-oxazaphosphorin-2-oxide,
CPA,
2-[Bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide hydrate,
2H-1,3,2-Oxazafosforin-2-amina, N,N-bis(2-cloroetil)tetrahidro-, 2-oxido, hidrato (1:1),
2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate,
Cyclophosphamide monohydrate, 97%, a nitrogen mustard alkylating agent - 1G 1g,
N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide hydrate (1:1),
|
| Complexity | 212 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 2 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 278.035g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 15 |
| Hydrogen Bond Acceptor Count | 5 |
| Hydrogen Bond Donor Count | 2 |
| Isotope Atom Count | 0 |
| Molecular Weight | 279.098g/mol |
| Monoisotopic Mass | 278.035g/mol |
| Rotatable Bond Count | 5 |
| Topological Polar Surface Area | 42.6A^2 |
| Undefined Atom Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
GHS Hazard and Precautionary Statements
| Symbol: |   |
| Hazard Class | 6.1 |
| Hazard statements | H301-H350 |
| Packing Group | Ⅲ |
| Precautionary statements | P201-P301+P310-P308+P313 |
| UN Code | UN 3464 |
Certificate of Analysis
Lot Number
Related Research Chemicals
CERTIFICATE OF ANALYSIS
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
Analysis Data:
| Test: | Result: |
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited